Expression of transforming growth factor-β-responsive smads in cranial suture development and closure

Journal of Craniofacial Surgery

Volumn 22, Issue 1, 2011, Pages 324-328

  Tholpady, Sunil S ^a   Ogle, Roy C ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Lifenet Health   (United States)

Author keywords

Cranial suture; craniosynostosis; smad; transforming growth factor

Indexed keywords

RECEPTOR REGULATED SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CRANIAL SUTURE; ENZYME IMMUNOASSAY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NEWBORN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; CRANIAL SUTURES; IMMUNOENZYME TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD PROTEINS, RECEPTOR-REGULATED; TRANSFORMING GROWTH FACTOR BETA;

EID: 79551609531     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181f7dfa0     Document Type: Article

References (23)

1. Ogle RC. Development and growth of the neurocranium. In: L KY, Ogle RC, and Jane JA, eds. Craniofacial Surgery: Science and Surgical Technique. Philadelphia, PA: WB Saunders, 2002:64-74
2. Britto JA, Evans RD, Hayward RD, et al. From genotype to phenotype: The differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes. Plast Reconstr Surg 2001;108: 2026-2039
3. Wilkie AO, Oldridge M, Tang Z, et al. Craniosynostosis and related limb anomalies. Novartis Found Symp 2001;232:122-133
4. Wilkie AO. Craniosynostosis: Genes and mechanisms. Hum Mol Genet 1997;6:1647-1656
5. Song HM, Fong KD, Nacamuli RP, et al. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus. Plast Reconstr Surg 2004;113: 1685-1697
6. Roth DA, Gold LI, Han VK, et al. Immunolocalization of transforming growth factor betal, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion (see comment). Plast Reconstr Surg 1997;99:300-309
7. Opperman LA, Nolen AA, Ogle RC. TGF-betal, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro (see comment). J Bone Miner Res 1997;12:301-310
8. Longaker MT. Role of TGF-beta signaling in the regulation of programmed cranial suture fusion. J Craniofac Surg 2001;12:389-390
9. Derynck R, Zhang Y, Feng XH. Smads: Transcriptional activators of TGF-beta responses. Cell 1998;95:737-740
10. Attisano L, Wrana JL. Smads as transcriptional co-modulators. Curr Opin Cell Biol 2000;12:235-243
11. Derynck R, Gelbart WM, Harland RM, et al. Nomenclature: Vertebrate mediators of TGFbeta family signals. Cell 1996;87:173
12. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-584
13. Ogle RC. Craniofacial skeletal morphogenesis in vitro. Methods Mol Biol 2000;136:55-59
14. Gagan JR, Tholpady SS, Ogle RC. Cellular dynamics and tissue interactions of the dura mater during head development. Birth Defects Res C Embryo Today 2007;81:297-304
15. Morriss-Kay GM, Iseki S, Johnson D. Genetic control of the cell proliferationYdifferentiation balance in the developing skull vault: Roles of fibroblast growth factor receptor signalling pathways. Novartis Found Symp 2001;232:102-116
16. Johnson D, Iseki S, Wilkie AO, et al. Expression patterns of Twist and FGFR1, -2 and -3 in the developing mouse coronal suture suggest a key role for twist in suture initiation and biogenesis. Mech Dev 2000;91:341-345
17. Opperman LA, Chhabra A, Cho RW, et al. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro. J Craniofac Genet Dev Biol 1999;19:164-173
18. Opperman LA, Adab K, Gakunga PT. Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dyn 2000;219:237-247
19. Waldrip WR, Bikoff EK, Hoodless PA, et al. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 1998;92:797-808
20. Weinstein M, Yang X, Li C, et al. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad 2. Proc Natl Acad Sci U S A 1998;95: 9378-9383
21. Nomura M, Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development (see comment). Nature 1998;393:786-790
22. Datto MB, Frederick JP, Pan L, et al. Targeted disruption of Smad3 reveals an essential role in transforming growth factor betaYmediated signal transduction. Mol Cell Biol 1999;19:2495-2504
23. Ashcroft GS, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response (see comment). Nat Cell Biol 1999;1:260-266